Cassava sciences to present at the h.c. wainwright global life sciences conference

Austin, texas, march 08, 2021 (globe newswire) -- cassava sciences, inc. (nasdaq: sava), a clinical-stage biotechnology company developing product candidates for alzheimer's disease, has been invited to present at the h.c. wainwright global life sciences conference, a virtual event being held tuesday, march 9th, and wednesday, march 10th, 2021. management is scheduled to present and will participate in virtual one-on-one meetings with institutional analysts and investors throughout the conference.
SAVA Ratings Summary
SAVA Quant Ranking